<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">30765911</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>09</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0312-8008</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>42</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Australian prescriber</Title>
          <ISOAbbreviation>Aust Prescr</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Rufinamide for seizures.</ArticleTitle>
        <Pagination>
          <StartPage>38</StartPage>
          <EndPage>39</EndPage>
          <MedlinePgn>38-39</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.18773/austprescr.2018.074</ELocationID>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>12</Month>
          <Day>13</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Aust Prescr</MedlineTA>
        <NlmUniqueID>7804938</NlmUniqueID>
        <ISSNLinking>0312-8008</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Inovelon</Keyword>
        <Keyword MajorTopicYN="N">rufinamide</Keyword>
        <Keyword MajorTopicYN="N">seizures</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>2</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>2</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>2</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30765911</ArticleId>
        <ArticleId IdType="pmc">PMC6370605</ArticleId>
        <ArticleId IdType="doi">10.18773/austprescr.2018.074</ArticleId>
        <ArticleId IdType="pii">austprescr-42-38</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Glauser T, Kluger G, Sachdeo R, Krauss G, Perdomo C, Arroyo S.
Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology
2008;70:1950-8. 10.1212/01.wnl.0000303813.95800.0d</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/01.wnl.0000303813.95800.0d</ArticleId>
            <ArticleId IdType="pubmed">18401024</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
